Ker-Chau Li

Title: Innovations by Ker-Chau Li in Lung Cancer Detection.

Introduction

Ker-Chau Li is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of lung cancer. His innovative approach has the potential to improve early diagnosis and treatment outcomes for patients at risk.

Latest Patents

Ker-Chau Li holds a patent for a method or kit for determining lung cancer development. This patent discloses a method for assessing whether a subject has or is at risk of developing lung cancer. The key aspect of this invention is the identification of the SNP locus of rs193100333, which corresponds to a mutation on the YAP1 protein. This mutation involves a substitution of an arginine to a tryptophan at position 331, indicating a risk for lung cancer. Additionally, the patent includes a kit designed to facilitate the detection of this specific SNP locus.

Career Highlights

Ker-Chau Li is affiliated with National Taiwan University, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on lung cancer diagnostics. With a focus on genetic markers, he aims to enhance the accuracy of cancer risk assessments.

Collaborations

Some of his notable coworkers include Bing-Ching Ho and Sung-Liang Yu. Their collaborative efforts contribute to advancing research in cancer detection and treatment methodologies.

Conclusion

Ker-Chau Li's contributions to lung cancer detection through his innovative patent highlight the importance of genetic research in medical diagnostics. His work at National Taiwan University continues to pave the way for advancements in early cancer detection and patient care.